THE CONAFAY GROUP, LLC

Lobbying for KIRIN BIOMATERIALS · Pharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $30,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Manufacturing

Support for the manufacture of bulk pharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem